Connecting Ideas and Audiences

Our blog serves as a glimpse into areas of interest for ourselves and our partners.

Rheumatology news - 2019-Nov-27th

Rheumatology: FDA approves adalimumab (Humira) biosimilar

https://www.pfizer.com/news/press-release/press-release-detail/fda_approves_pfizer_s_biosimilar_abrilada_adalimumab_afzb_for_multiple_inflammatory_conditions

James WestbrooksNovember 27, 2019